Skip to content
Forcyte Biotechnologies, Inc

the function-first biology company

Menu
  • Company
    • VISION
    • ABOUT
    • TEAM
    • NEWS
    • CONTACT
  • Platform
    • FLECS TECHNOLOGY
    • PUBLICATIONS
  • Mechanomics
    • MECHANOMIC DISEASES
    • PIPELINE

Category: Conferences

Conferences

Forcyte Bio to participate in Innovation AveNEW for Startups Showcase at SLAS 2019

Forcyte has been selected as 1 of 8 companies given a presentation space at the Society of Laboratory Automation and Screening annual meeting in Washington D.C. on Feb 4-6. We …

Conferences

Forcyte is attending RESI San Francisco Jan 9th!

We’re excited to be attending the 2018 San Francisco edition of the RESI Series on January 9th, 2018! Dr. Pushkarsky will be on the floor sharing our technology and seeking …

Recent Posts

  • Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million
  • Forcyte awarded Phase 2 SBIR by NIH / NCATS to develop pseudo-3D contractile “tissuoid” assay enabling study of coordinated cell contractions and tachyphylaxis
  • New App Note covering FLECS Technology in collaboration with Molecular Devices is now available:
  • Forcyte’s Cardiac Tissuoid assay is now available
  • Forcyte Bio to participate in Innovation AveNEW for Startups Showcase at SLAS 2019

Recent Comments

    Archives

    • June 2022
    • September 2019
    • May 2019
    • January 2019
    • July 2018
    • April 2018
    • March 2018
    • November 2017

    Categories

    • Conferences
    • Funding
    • New Materials
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2017 Forcyte Biotechnologies, Inc